Exonate

Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration.

02Backed By1 investor

WCWren Capital LLP→

03Similar Companies

MP

Is this your company? Claim your profile

Minghui Pharmaceutical

Biotech & Life Sciences

→

TP

Tarsus Pharmaceuticals

Biotech & Life Sciences

→

O

Omeros

Biotech & Life Sciences

→

ZO

Zhaoke Ophthalmology

Biotech & Life Sciences

→

F

Fulcrum/Ception

Biotech & Life Sciences

→

04Startup DNA

7

signals

Sectors
Business Model
Technology